Around the Web

Doctors warn some popular weight-loss drugs may raise risk of complications under anesthesia

, August 14, 2023

Pharma

Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia.

Nearly all hospital pharmacists say drug shortages are negatively impacting care; a third say impacts are 'critical'

, August 11, 2023

Pharma

As drug shortages near record levels in the United States, a new survey shows how widespread — and serious — the effects are.

SCOTUS pauses Purdue Pharma bankruptcy settlement

, August 11, 2023

Pharma

The U.S. Supreme Court has temporarily blocked Purdue Pharma's plan to emerge from bankruptcy that shielded the founding Sackler families from liability in the nation's opioid epidemic.

Novo Nordisk to buy Inversago Pharma for up to $1.1B

, August 10, 2023

Pharma

Wegovy maker Novo Nordisk A/S agreed to buy Inversago Pharma, a maker of experimental obesity and diabetes treatments, for as much as $1.08 billion.

Opinion: Drugs like Wegovy could be revolutionary — if we can afford them

, August 10, 2023

Pharma

Like all drugs, these have side effects, including a searing, persistent pain in the wallet: They list for $1,000 to $1,300 a month.

Viewpoint: CalRx biosimilar insulin: CA's initiative to enter the insulin market

, August 8, 2023

Pharma

Around the Web

Doctors warn some popular weight-loss drugs may raise risk of complications under anesthesia

Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia.

Nearly all hospital pharmacists say drug shortages are negatively impacting care; a third say impacts are 'critical'

As drug shortages near record levels in the United States, a new survey shows how widespread — and serious — the effects are.

SCOTUS pauses Purdue Pharma bankruptcy settlement

The U.S. Supreme Court has temporarily blocked Purdue Pharma's plan to emerge from bankruptcy that shielded the founding Sackler families from liability in the nation's opioid epidemic.

Novo Nordisk to buy Inversago Pharma for up to $1.1B

Wegovy maker Novo Nordisk A/S agreed to buy Inversago Pharma, a maker of experimental obesity and diabetes treatments, for as much as $1.08 billion.

Opinion: Drugs like Wegovy could be revolutionary — if we can afford them

Like all drugs, these have side effects, including a searing, persistent pain in the wallet: They list for $1,000 to $1,300 a month.

Viewpoint: CalRx biosimilar insulin: CA's initiative to enter the insulin market

California's pending entry into the insulin market is a response to decades of consistent and steep price increases for insulin products.

Pages

Search form

Around the Web

Doctors warn some popular weight-loss drugs may raise risk of complications under anesthesia

Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia.

Nearly all hospital pharmacists say drug shortages are negatively impacting care; a third say impacts are 'critical'

As drug shortages near record levels in the United States, a new survey shows how widespread — and serious — the effects are.

SCOTUS pauses Purdue Pharma bankruptcy settlement

The U.S. Supreme Court has temporarily blocked Purdue Pharma's plan to emerge from bankruptcy that shielded the founding Sackler families from liability in the nation's opioid epidemic.

Novo Nordisk to buy Inversago Pharma for up to $1.1B

Wegovy maker Novo Nordisk A/S agreed to buy Inversago Pharma, a maker of experimental obesity and diabetes treatments, for as much as $1.08 billion.

Opinion: Drugs like Wegovy could be revolutionary — if we can afford them

Like all drugs, these have side effects, including a searing, persistent pain in the wallet: They list for $1,000 to $1,300 a month.

Viewpoint: CalRx biosimilar insulin: CA's initiative to enter the insulin market

California's pending entry into the insulin market is a response to decades of consistent and steep price increases for insulin products.

Pages